Cheng Zeng

10PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysisMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2026
Low-Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer.

|Jun 29, 2026
Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer.

|Apr 13, 2026
The Burden of Breast Cancer and its Attributable Risk Factors in 204 Countries and Territories, 1990-2021: Results From the Global Burden of Disease Study 2021.

Jiahui Huang, Jiajin Li, Shengbin Pei

|Dec 24, 2025
The Role of DNA Methyltransferases in Urinary System Diseases.

Wei Dong, Shengbin Pei, Dacheng Zhu

|Sep 25, 2025
Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis.

Cheng Zeng, Shuning Liu, Yuhan Wei

|Aug 16, 2025
A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion.

Cheng Zeng, Yujing Tan, Zhimin Jiao

Pageof 2

Frequent Collaborators

5 joint publications

Fei Ma

2 joint publications

Yujing Tan

2 joint publications

Shengbin Pei

1 joint publications

Huayi Yu